Nabriva Therapeutics plc Quarterly Entity Common Stock, Shares Outstanding from Q1 2017 to Q3 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Nabriva Therapeutics plc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2017 to Q3 2023.
  • Nabriva Therapeutics plc Entity Common Stock, Shares Outstanding for the quarter ending September 11, 2023 was 3.23M shares, a 5.45% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 3.23M +167K +5.45% Sep 11, 2023 10-Q 2023-10-19
Q1 2023 3.2M -60M -94.9% Apr 30, 2023 10-Q 2023-05-22
Q3 2022 3.06M -51.3M -94.4% Oct 31, 2022 10-Q 2022-11-10
Q2 2022 66.5M +16.8M +33.8% Jul 31, 2022 10-Q 2022-08-03
Q1 2022 63.2M +27.8M +78.4% Apr 30, 2022 10-Q 2022-05-05
Q3 2021 54.3M -96.5M -64% Oct 31, 2021 10-Q 2021-11-09
Q2 2021 49.7M -94.1M -65.4% Jul 31, 2021 10-Q 2021-08-05
Q1 2021 35.4M -64.6M -64.6% Apr 30, 2021 10-Q 2021-05-06
Q3 2020 151M +72.4M +92.4% Oct 31, 2020 10-Q 2020-11-05
Q2 2020 144M +70.5M +96% Jul 31, 2020 10-Q 2020-08-06
Q1 2020 100M +27.4M +37.8% Apr 30, 2020 10-Q 2020-05-11
Q3 2019 78.4M +11.4M +17% Oct 31, 2019 10-Q 2019-11-12
Q2 2019 73.4M +6.88M +10.3% Jul 30, 2019 10-Q 2019-08-08
Q1 2019 72.6M +32.3M +80% Apr 30, 2019 10-Q 2019-05-10
Q3 2018 67M +30.3M +82.6% Oct 26, 2018 10-Q 2018-11-06
Q2 2018 66.5M +39.6M +148% Jul 31, 2018 10-Q 2018-08-09
Q1 2018 40.3M +37.6M +1381% Apr 30, 2018 10-Q 2018-05-08
Q3 2017 36.7M Nov 3, 2017 10-Q 2017-11-09
Q2 2017 26.8M Jul 15, 2017 10-Q 2017-08-07
Q1 2017 2.72M Apr 30, 2017 10-Q 2017-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.